EU drugs regulator backs higher dose of Novo's Wegovy

Core Viewpoint - Novo Nordisk announced that the European Medicines Agency's committee has issued a positive opinion for a 7.2 mg dose of the weight-loss drug Wegovy, which offers an option for greater weight loss [1] Group 1 - The European Medicines Agency's committee has provided a positive opinion regarding the 7.2 mg dosage of Wegovy [1] - This new dosage aims to enhance weight loss effectiveness for patients [1]